Religious communities to end TB (ReCET)
Religious communities to end TB (ReCET)
批准号:
372880
负责人:
Menzies Richard
金额:
$1.42万
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-08-01 至 2018-08-01
中文摘要
南非夸祖鲁-纳塔尔省的宗教领袖担心他们社区的结核病或“结核病”。结核病导致的死亡人数超过任何其他传染病,包括艾滋病。人们因吸入病人的细菌而感染结核病。”
英文摘要
Faith leaders in the province of KwaZulu-Natal, South Africa are concerned about Tuberculosis or "TB" in their communities. TB kills more people than any other contagious disease, including AIDS. People get TB from breathing in the germs of a sick person'
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
-
批准号:415507
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2019
-
负责人:Menzies Richard
-
依托单位:
Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.
-
批准号:311618
-
项目类别:Operating Grants
-
资助金额:$575.5万
-
财政年份:2014
-
负责人:Menzies Richard
-
依托单位:
Evaluation of potential biomarkers of successful treatment of latent tuberculosis
-
批准号:223992
-
项目类别:Operating Grants
-
资助金额:$38.29万
-
财政年份:2011
-
负责人:Menzies Richard
-
依托单位:
A randomized trial to compare effectiveness of 4 months Rifampin (4 RIF) with 9 months Isoniazid (9 INH) in the prevention of active TB in children: The P4v9 Trial
-
批准号:210714
-
项目类别:Operating Grants
-
资助金额:$74.57万
-
财政年份:2010
-
负责人:Menzies Richard
-
依托单位:
A Randomized Trial of 4 Months Rifampin vs. 9 Months Isoniazid for Latent Tuberculosis Infection. Part 3 - Effectiveness
-
批准号:170718
-
项目类别:Randomized Controlled Trials
-
资助金额:$352.75万
-
财政年份:2008
-
负责人:Menzies Richard
-
依托单位:
海外基金